How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?: A Redefinition of Evidence-Based Medicine

Circulation. 2021 Mar 2;143(9):875-877. doi: 10.1161/CIRCULATIONAHA.120.052926. Epub 2020 Dec 30.
No abstract available

Keywords: adrenergic beta-antagonists; aldosterone; angiotensin converting enzyme inhibitors; heart failure; neprilysin; receptors, mineralocorticoid; sodium-glucose transport proteins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Algorithms*
  • Angiotensin Receptor Antagonists / therapeutic use
  • Evidence-Based Medicine / methods*
  • Heart Failure / drug therapy
  • Heart Failure / physiopathology
  • Humans
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Neprilysin / antagonists & inhibitors
  • Sodium-Glucose Transporter 2 Inhibitors / therapeutic use
  • Stroke Volume

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin Receptor Antagonists
  • Mineralocorticoid Receptor Antagonists
  • Sodium-Glucose Transporter 2 Inhibitors
  • Neprilysin